But in the many scrutiny of Purdue and OxyContin, the trouble of the drug putting on off early was not resolved. In a 2004 letter into the FDA, Purdue legal professionals responded that the business had no evidence that eight­-hour prescribing contributed to abuse or was unsafe. reduce the